Manchester Imaging, a Manchester, UK-based dental diagnostic software company, raised £600k in funding.
Backers included the GM&C Life Sciences Fund, managed by Catapult Ventures, and NPIF – Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund. In addition to the investment, Kevin D’Silva, a Venture Partner with Catapult Ventures, will join the board of Manchester Imaging as non-executive Chairman.
The company intends to use the funds for the development and commercial launch of its first suite of software products.
Led by Tony Travers, CEO, Manchester Imaging has developed diagnostic software that uses machine learning and computer vision processes to automatically detect the very early signs of tooth decay, which can go unseen by dentists, empowering patients to look after their teeth effectively and saving money for insurance companies and governments by reducing the need for dental restorations and repairs.
A spin-out of The University of Manchester by its agent for IP commercialisation, UMI3 Ltd, the company is based on more than a decade of academic collaboration between Professor Hugh Devlin, Professor of Restorative Dentistry, and Dr Jim Graham, Honorary Reader in the Centre for Imaging Science.